UBER TECHNOLOGIES, INC. v. X ONE, INC.
Before Prost, Dyk, and Wallach. Appeal from the U.S. Patent and Trademark Office, Patent Trial and Appeal Board.
Summary: Because a mapping technique must be performed on either a...more
EKO BRANDS, LLC V. ADRIAN RIVERA MAYNEZ ENTERPRISES, INC. ET. AL.
Before Dyk, Reyna, and Hughes. Reyna dissenting in part. Appeal from the Western District of Washington...more
Federal Circuit Summary -
Before Newman, Hughes, and Stoll. Appeal from the United States District Court for the District of Delaware
Summary: Objective indicia of nonobviousness cannot be dismissed merely because all...more
9/14/2018
/ Actavis Inc. ,
Appeals ,
Generic Drugs ,
Hatch-Waxman ,
Investigational New Drug Application (IND) ,
Nonobvious ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal
Federal Circuit Summary -
Before O’Malley, Mayer, and Reyna. Appeal from the Patent Trial and Appeal Board.
Summary: Claims may be rejected under 35 § U.S.C. 103 based on implicit disclosures of a prior art reference....more
9/11/2018
/ Appeals ,
Apple ,
Motivation to Combine ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reaffirmation ,
Samsung ,
Section 103 ,
Software Patents ,
Substantial Evidence Standard
Federal Circuit Summary -
Before Prost, Dyk, and O’Malley. Appeal from the Patent and Trial Appeal Board.
Summary: An IPR petitioner lacks standing to appeal an adverse decision by the Board if it sells no infringing...more
8/8/2018
/ Appeals ,
Article III ,
Injury-in-Fact ,
Inter Partes Review (IPR) Proceeding ,
Noninfringement ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Standing
Federal Circuit Summary -
Before Frost, Newman, and Lawrie. Appeal from the U.S. District Court for the Eastern District of Texas.
Summary: A weak showing of secondary considerations is insufficient to create a genuine...more
Federal Circuit Summaries -
Before Dyk, O’Malley, and Wallach. Appeal from the PTAB.
Summary: A priority claim must be explicitly stated in the patent and cannot be incorporated by reference from an earlier patent. ...more
Federal Circuit Summaries -
Before Lourie, Reyna, and Taranto. Appeal from the Patent Trial and Appeal Board.
Summary: A prima facie case of obviousness is established where the claimed range abuts a range disclosed in...more
The Federal Circuit held that a rat study in a provisional application and a conversion method in an uncited reference did not support the claimed human dosage form in Los Angeles Biomed. Research Inst. v. Eli Lilly & Co.,...more